Home Alnylam Acquires Investigational RNAi Therapeutic Assets from Merck
 

Keywords :   


Alnylam Acquires Investigational RNAi Therapeutic Assets from Merck

2014-01-13 07:51:19| Biotech - Topix.net

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today the acquisition of Merck's wholly owned subsidiary Sirna Therapeutics, Inc. , comprising intellectual property and RNAi assets including pre-clinical therapeutic candidates, chemistry, siRNA-conjugate and other delivery technologies.

Tags: assets therapeutic acquires merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11NERF RAIDER CS-35 N-STRIKE 35
14.11Epiphone SGG400
14.11PHILWOOD×H PLUS SON* track wheel
14.1125th
14.1110.5
14.11
14.11JAKO 96
14.11
More »